Oragenics (NYSEAMERICAN:OGEN) Trading Up 1.9% – Still a Buy?

Oragenics, Inc. (NYSEAMERICAN:OGEN)’s share price was up 1.9% on Thursday . The stock traded as high as $0.9372 and last traded at $0.9372. Approximately 20,843 shares changed hands during mid-day trading, a decline of 59% from the average daily volume of 50,468 shares. The stock had previously closed at $0.92.

Oragenics Stock Performance

The business’s 50 day simple moving average is $0.91 and its 200-day simple moving average is $1.14. The company has a market cap of $3.96 million, a price-to-earnings ratio of -0.08 and a beta of 0.90.

Oragenics (NYSEAMERICAN:OGEN) last posted its quarterly earnings results on Friday, November 7th. The company reported ($1.96) earnings per share for the quarter.

Institutional Investors Weigh In On Oragenics

Several institutional investors have recently made changes to their positions in OGEN. Bank of America Corp DE increased its holdings in Oragenics by 7,374.0% in the second quarter. Bank of America Corp DE now owns 15,546 shares of the company’s stock worth $59,000 after buying an additional 15,338 shares during the last quarter. Sabby Management LLC bought a new stake in Oragenics in the third quarter worth approximately $77,000. Finally, Clear Street LLC bought a new stake in Oragenics in the second quarter worth approximately $270,000. 18.71% of the stock is currently owned by institutional investors and hedge funds.

About Oragenics

Oragenics, Inc is a clinical-stage biotechnology company focused on the research and development of novel anti-infective therapeutics targeting oral and mucosal diseases. Headquartered in Tampa, Florida, the company leverages proprietary technologies to address unmet needs in dental and oral healthcare, with an emphasis on innovative treatments that can improve patient outcomes and reduce reliance on traditional antibiotics.

The company’s lead product candidate, Oraprev™, is being developed as a pre-procedural rinse designed to reduce oral microbial load prior to dental procedures.